Status: Recruiting
Reduction of Adverse Drug Events and Readmissions
Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.
Participants needed: 280,000
Trial details
Age: 25+Biological sex: AllType: ObservationalSponsor: ClinLogic LLCUpdated: Feb 7, 2024Locations: 1Duration: 120 Days
Eligibility criteria
Male or female patients of 25 years of age or older who are able to give their w... [+3]
Patient is currently hospitalized; [+3]